| Pharmaceutical active ingredients: |
| Tositumomab Iodine, I-131 |
| Available forms, composition and doses of Bexxar: |
| Injectable; Injection; Iodine I 131 Tositumomab 0.1-0.25 mg / mlInjectable; Injection; Iodine I 131 Tositumomab 1.1-2.5 mg / mlInjectable; Injection; Iodine I 131 Tositumomab 14 mg / ml |
| Bexxar medical category: |
| Human:Antineoplastic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V10XA53 - Tositumomab / Iodine I-131 Tositumomab |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKlineCorixa |
| Related documents and information about Bexxar: |
| Bexxar prescribing information (PDF) |